Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Access to first- and second-generation human papillomavirus (HPV) vaccines that are expected to lower the risk for HPV-associated cancers in all racial/ethnic groups is the main finding of the recent study, “Racial ... Read more
The vaccination program for human papillomavirus (HPV) resulted in a 64 percent reduction of HPV prevalence in teenage girls age 14-19, according to a study titled “Prevalence of HPV After Introduction of the ... Read more
A Swedish nationwide study in women with rheumatoid arthritis (RA) found an elevated risk for cervical dysplasia in those treated with tumor necrosis factor (TNF) inhibitors, a common RA therapy. ... Read more
Pin It on Pinterest